Jacobi Capital Management LLC Ligand Pharmaceuticals Inc Transaction History

Jacobi Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$99.52 - $215.83 $1,293 - $2,805	-13 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$89.56 - $126.72 $8,956 - $12,672	-100 Reduced 88.5%	13 $1,000
Q2 2020 Aug 04, 2020	BUY	$68.28 - $123.65 $6,964 - $12,612	102 Added 927.27%	113 $13,000
Q2 2020 Jul 27, 2020	SELL	$68.28 - $123.65 $6,964 - $12,612	-102 Reduced 90.27%	11 $13,000
Q1 2020 Apr 24, 2020	BUY	$63.37 - $107.88 $823 - $1,402	13 Added 13.0%	113 $8,000
Q4 2018 Feb 11, 2019	SELL	$128.36 - $272.13 $32,090 - $68,032	-250 Reduced 71.43%	100 $14,000
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $73,913 - $96,071	350 New	350 $96,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.